Global Next Generation Cancer Diagnostics Market Analysis & Trends - Function, Application, Cancer Type, Technology - Forecast to 2025

  • ID: 3971866
  • Report
  • Region: Global
  • 154 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • GE Healthcare
  • Hologic Inc.
  • Johnson & Johnson
  • Novartis AG
  • Perkin Elmer Inc.
  • MORE

"Global Next Generation Cancer Diagnostics Market Analysis & Trends - Function (Cancer Screening), Application (Biomarker Development, Genetic Analysis), Cancer Type (Lung Cancer and Blood-born cancers),Technology (Next Generation Sequencing) - Forecast to 2025"

The Global Next Generation Cancer Diagnostics Market is poised to grow at a CAGR of around 28.6% over the next decade to reach approximately $44.6 billion by 2025. Some of the prominent trends that the market is witnessing include increasing demand for companion diagnostics, customized medicines gaining popularity, recent technological developments of Next Generation Cancer Diagnostics and growth opportunities/investment opportunities.

Based on function the market is categorized into cancer screening, therapeutic monitoring, prognosis diagnostics, risk analysis and companion diagnostics. Based on application market is categorized into biomarker development, proteomic analysis, genetic analysis, CTC analysis and epigenetic analysis. Depending on the cancer type the market is segmented by lung cancer, sex-related tumors and blood-born cancers. Lung cancer further divided into colorectal cancer, solid tumors and other cancers. Sex-related tumors further segmented into prostate cancer, breast cancer, cervical cancer and ovarian cancer. Blood-born cancers further segmented into lymphoma, myeloma and leukemia.

Based on technology the market is categorized into RT-PCR & multiplexing, benchtop sequencers, lab-on-a-chip, cellular capture and identification, multiplexed assays, next generation sequencing, DNA microarrays, protein microarrays and other technologies.

This industry report analyzes the global markets for Next Generation Cancer Diagnostics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Next Generation Cancer Diagnostics Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • GE Healthcare
  • Hologic Inc.
  • Johnson & Johnson
  • Novartis AG
  • Perkin Elmer Inc.
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Application Analysis
1.5 Technology Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Increasing Demand for Companion Diagnostics
3.1.2 Customized Medicines Gaining Popularity
3.1.3 Recent Technological Developments of Next Generation Cancer Diagnostics
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Next Generation Cancer Diagnostics Market, By Function
4.1 Cancer Screening
4.1.1 Cancer Screening Market Forecast to 2025 (US$ MN)
4.2 Therapeutic Monitoring
4.2.1 Therapeutic Monitoring Market Forecast to 2025 (US$ MN)
4.3 Prognosis Diagnostics
4.3.1 Prognosis Diagnostics Market Forecast to 2025 (US$ MN)
4.4 Risk Analysis
4.4.1 Risk Analysis Market Forecast to 2025 (US$ MN)
4.5 Companion Diagnostics
4.5.1 Companion Diagnostics Market Forecast to 2025 (US$ MN)

5 Next Generation Cancer Diagnostics Market, By Application
5.1 Biomarker Development
5.1.1 Biomarker Development Market Forecast to 2025 (US$ MN)
5.2 Proteomic Analysis
5.2.1 Proteomic Analysis Market Forecast to 2025 (US$ MN)
5.3 Genetic Analysis
5.3.1 Genetic Analysis Market Forecast to 2025 (US$ MN)
5.4 CTC Analysis
5.4.1 CTC Analysis Market Forecast to 2025 (US$ MN)
5.5 Epigenetic Analysis
5.5.1 Epigenetic Analysis Market Forecast to 2025 (US$ MN)

6 Next Generation Cancer Diagnostics Market, By Cancer Type
6.1 Lung Cancer
6.1.1 Lung Cancer Market Forecast to 2025 (US$ MN)
6.1.1.1 Colorectal Cancer
6.1.1.1.1 Colorectal Cancer Market Forecast to 2025 (US$ MN)
6.1.1.2 Solid tumors
6.1.1.2.1 Solid tumors Market Forecast to 2025 (US$ MN)
6.1.1.3 Other Cancers
6.1.1.3.1 Other Cancers Market Forecast to 2025 (US$ MN)
6.2 Sex-related tumors
6.2.1 Sex-related tumors Market Forecast to 2025 (US$ MN)
6.2.1.1 Prostate Cancer
6.2.1.1.1 Prostate Cancer Market Forecast to 2025 (US$ MN)
6.2.1.2 Breast Cancer
6.2.1.2.1 Breast Cancer Market Forecast to 2025 (US$ MN)
6.2.1.3 Cervical Cancer
6.2.1.3.1 Cervical Cancer Market Forecast to 2025 (US$ MN)
6.2.1.4 Ovarian Cancer
6.2.1.4.1 Ovarian Cancer Market Forecast to 2025 (US$ MN)
6.3 Blood-born cancers
6.3.1 Blood-born cancers Market Forecast to 2025 (US$ MN)
6.3.1.1 Lymphoma
6.3.1.1.1 Lymphoma Market Forecast to 2025 (US$ MN)
6.3.1.2 Myeloma
6.3.1.2.1 Myeloma Market Forecast to 2025 (US$ MN)
6.3.1.3 Leukemia
6.3.1.3.1 Leukemia Market Forecast to 2025 (US$ MN)

7 Next Generation Cancer Diagnostics Market, By Technology
7.1 RT-PCR & Multiplexing
7.1.1 RT-PCR & Multiplexing Market Forecast to 2025 (US$ MN)
7.2 Benchtop Sequencers
7.2.1 Benchtop Sequencers Market Forecast to 2025 (US$ MN)
7.3 Lab-on-a-chip
7.3.1 Lab-on-a-chip Market Forecast to 2025 (US$ MN)
7.4 Cellular capture and identification
7.4.1 Cellular capture and identification Market Forecast to 2025 (US$ MN)
7.5 Multiplexed assays
7.5.1 Multiplexed assays Market Forecast to 2025 (US$ MN)
7.6 Next Generation Sequencing
7.6.1 Next Generation Sequencing Market Forecast to 2025 (US$ MN)
7.7 DNA Microarrays
7.7.1 DNA Microarrays Market Forecast to 2025 (US$ MN)
7.8 Protein Microarrays
7.8.1 Protein Microarrays Market Forecast to 2025 (US$ MN)
7.9 Other Technologies
7.9.1 Other Technologies Market Forecast to 2025 (US$ MN)

8 Next Generation Cancer Diagnostics Market, By Geography
8.1 North America
8.1.1 North America Market Forecast by Countries to 2028 (US$ MN)
8.1.1.1 US
8.1.1.2 Canada
8.1.1.3 Mexico
8.2 Europe
8.2.1 Europe Market Forecast by Countries to 2028 (US$ MN)
8.2.1.1 France
8.2.1.2 Germany
8.2.1.3 Italy
8.2.1.4 Spain
8.2.1.8 U.K.
8.2.1.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Asia Pacific Market Forecast by Countries to 2028 (US$ MN)
8.3.1.1 Japan
8.3.1.2 China
8.3.1.3 India
8.3.1.4 Australia
8.3.1.8 New Zealand
8.3.1.6 Rest of APAC
8.4 Middle East
8.4.1 Middle East Market Forecast by Countries to 2028 (US$ MN)
8.4.1.1 Saudi Arabia
8.4.1.2 UAE
8.4.1.3 Rest of Middle East
8.8 Latin America
8.8.1 Latin America Market Forecast by Countries to 2028 (US$ MN)
8.8.1.1 Argentina
8.8.1.2 Brazil
8.8.1.3 Rest of Latin America
8.8 Rest of the World (RoW)
8.8.1 RoW Market Forecast by Countries to 2028 (US$ MN)
8.8.1.1 Africa
8.8.1.2 Caribbean

9 Key Player Activities
9.1 Mergers & Acquisitions
9.2 Partnerships, Joint Venture’s, Collaborations and Agreements
9.3 Product Launch & Expansions
9.4 Other Activities

10 Leading Companies
10.1 Johnson & Johnson
10.2 Qiagen
10.3 Abbott Laboratories
10.4 Hologic Inc.
10.5 Perkin Elmer Inc.
10.6 Agilent Technologies Inc
10.7 Thermo Fisher Scientific Inc.
10.8 Myriad Genetics Inc.
10.9 Genomic Health Inc.
10.10 Opko Health Inc.
10.11 GE Healthcare
10.12 Roche Holding AG
10.13 Novartis AG
10.14 Illumina Inc.
10.15 Philips Electronics NV

List of Tables

Table 1 Global Next Generation Cancer Diagnostics Market By Region, Market Forecast (2013-2025) (US$ MN)
Table 2 Global Next Generation Cancer Diagnostics Market By Function, Market Forecast (2013-2025) (US$ MN)
Table 3 Global Next Generation Cancer Diagnostics Market By Cancer Screening, Market Forecast (2013-2025) (US$ MN)
Table 4 Global Next Generation Cancer Diagnostics Market By Therapeutic Monitoring, Market Forecast (2013-2025) (US$ MN)
Table 5 Global Next Generation Cancer Diagnostics Market By Prognosis Diagnostics, Market Forecast (2013-2025) (US$ MN)
Table 6 Global Next Generation Cancer Diagnostics Market By Risk Analysis, Market Forecast (2013-2025) (US$ MN)
Table 7 Global Next Generation Cancer Diagnostics Market By Companion Diagnostics, Market Forecast (2013-2025) (US$ MN)
Table 8 Global Next Generation Cancer Diagnostics Market By Application, Market Forecast (2013-2025) (US$ MN)
Table 9 Global Next Generation Cancer Diagnostics Market By Biomarker Development, Market Forecast (2013-2025) (US$ MN)
Table 10 Global Next Generation Cancer Diagnostics Market By Proteomic Analysis, Market Forecast (2013-2025) (US$ MN)
Table 11 Global Next Generation Cancer Diagnostics Market By Genetic Analysis, Market Forecast (2013-2025) (US$ MN)
Table 12 Global Next Generation Cancer Diagnostics Market By CTC Analysis, Market Forecast (2013-2025) (US$ MN)
Table 13 Global Next Generation Cancer Diagnostics Market By Epigenetic Analysis, Market Forecast (2013-2025) (US$ MN)
Table 14 Global Next Generation Cancer Diagnostics Market By Cancer Type, Market Forecast (2013-2025) (US$ MN)
Table 15 Global Next Generation Cancer Diagnostics Market By Lung Cancer, Market Forecast (2013-2025) (US$ MN)
Table 16 Global Next Generation Cancer Diagnostics Market By Colorectal Cancer, Market Forecast (2013-2025) (US$ MN)
Table 17 Global Next Generation Cancer Diagnostics Market By Solid tumors, Market Forecast (2013-2025) (US$ MN)
Table 18 Global Next Generation Cancer Diagnostics Market By Other Cancers, Market Forecast (2013-2025) (US$ MN)
Table 19 Global Next Generation Cancer Diagnostics Market By Sex-related tumors, Market Forecast (2013-2025) (US$ MN)
Table 20 Global Next Generation Cancer Diagnostics Market By Prostate Cancer, Market Forecast (2013-2025) (US$ MN)
Table 21 Global Next Generation Cancer Diagnostics Market By Breast Cancer, Market Forecast (2013-2025) (US$ MN)
Table 22 Global Next Generation Cancer Diagnostics Market By Cervical Cancer, Market Forecast (2013-2025) (US$ MN)
Table 23 Global Next Generation Cancer Diagnostics Market By Ovarian Cancer, Market Forecast (2013-2025) (US$ MN)
Table 24 Global Next Generation Cancer Diagnostics Market By Blood-born cancers, Market Forecast (2013-2025) (US$ MN)
Table 25 Global Next Generation Cancer Diagnostics Market By Lymphoma, Market Forecast (2013-2025) (US$ MN)
Table 26 Global Next Generation Cancer Diagnostics Market By Myeloma, Market Forecast (2013-2025) (US$ MN)
Table 27 Global Next Generation Cancer Diagnostics Market By Leukemia, Market Forecast (2013-2025) (US$ MN)
Table 28 Global Next Generation Cancer Diagnostics Market By Technology, Market Forecast (2013-2025) (US$ MN)
Table 29 Global Next Generation Cancer Diagnostics Market By RT-PCR & Multiplexing, Market Forecast (2013-2025) (US$ MN)
Table 30 Global Next Generation Cancer Diagnostics Market By Benchtop Sequencers, Market Forecast (2013-2025) (US$ MN)
Table 31 Global Next Generation Cancer Diagnostics Market By Lab-on-a-chip, Market Forecast (2013-2025) (US$ MN)
Table 32 Global Next Generation Cancer Diagnostics Market By Cellular capture and identification, Market Forecast (2013-2025) (US$ MN)
Table 33 Global Next Generation Cancer Diagnostics Market By Multiplexed assays, Market Forecast (2013-2025) (US$ MN)
Table 34 Global Next Generation Cancer Diagnostics Market By Next Generation Sequencing, Market Forecast (2013-2025) (US$ MN)
Table 35 Global Next Generation Cancer Diagnostics Market By DNA Microarrays, Market Forecast (2013-2025) (US$ MN)
Table 36 Global Next Generation Cancer Diagnostics Market By Protein Microarrays, Market Forecast (2013-2025) (US$ MN)
Table 37 Global Next Generation Cancer Diagnostics Market By Other Technologies, Market Forecast (2013-2025) (US$ MN)

Note: Tables for North America, Europe, APAC, Middle East, Latin America and RoW Regions are also represented in the same manner as above.
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Agilent Technologies Inc
  • GE Healthcare
  • Genomic Health Inc.
  • Hologic Inc.
  • Illumina Inc.
  • Johnson & Johnson
  • Myriad Genetics Inc.
  • Novartis AG
  • Opko Health Inc.
  • Perkin Elmer Inc.
  • Philips Electronics NV
  • Qiagen
  • Roche Holding AG
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll